[Federal Register Volume 68, Number 103 (Thursday, May 29, 2003)]
[Notices]
[Page 32090]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-13308]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By notice dated April 11, 2002, and published in the Federal 
Register on April 26, 2002 (67 FR 20828), Salsbury Chemicals, Inc., 
1205 11th Street, Charles City, Iowa 50616-3466, made application by 
renewal to the Drug Enforcement Administration to be registered as a 
bulk manufacturer of Amphetamine (1100) and Methylphenidate (1724), 
both Schedule II controlled substances. The firm's legal name has since 
changed to Cambrex Charles City, Inc.
    The firm plans to manufacture amphetamine and methylphenidate for 
distribution as bulk product to its customers.
    No comments or objections have been received. DEA has considered 
the factors in title 21, United States Code, section 823(a) and 
determined that the registration of Cambrex Charles City, Inc. to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Cambrex Charles 
City, Inc. to ensure that the company's registration is consistent with 
the public interest. This investigation has included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 823 
and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office 
of Diversion Control, hereby orders that the application submitted by 
the above firm for registration as a bulk manufacturer of the basic 
classes of controlled substances listed is granted.

    Dated: May 7, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-13308 Filed 5-28-03; 8:45 am]
BILLING CODE 4410-09-M